(Reuters) – Britain’s drug regulator on Thursday approved GSK and Vir Biotechnology’s antibody based COVID-19 treatment, Xevudy, for people with mild-to-moderate COVID-19 who are at high risk of developing severe…
Investing.com – European stock markets traded higher Monday, only partially unwinding Friday’s hefty losses, with travel stocks benefiting as investors reassess the potential economic damage the newly discovered omicron Covid…
Investing.com – The dollar edged lower Wednesday, consolidating after strong gains during the previous session after Fed Chair Jerome Powell indicated the U.S. central bank is likely to speed up…
(Reuters) -British power generator Drax aims to double its sustainable biomass production capacity by 2030, to capitalise on increasing demand from Europe and Asia as countries transition away from coal.…